---
source: Differential Diagnosis in Small - Gough, Alex, Murphy, Kate.pdf
pages: 463
converted: 2026-02-01 19:52
part: chunk_024
estimated_tokens: 4009
---


434 Index



hepatitis, 6, 14, 125, 129, 139, 145,
238, 240, 307, 329, 356, 359,
386, 400, 402
acute, 299, 402
chronic, 173, 259, 297, 299, 308,
316, 318, 319, 328, 396
hepatobiliary disease, 6, 10, 115, 139
biliary obstruction, 297
caudal vena cava and hepatic veins,
dilatation, 298
decreased echogenicity, 297
diffuse hepatic disease, 297
gall bladder wall thickening, 299
hepatic parenchymal abnormalities,
298–9
increased echogenicity, gall
bladder, 299
hepatocellular damage, 334
hepatomegaly, 9, 138, 150, 242, 245,
249, 250, 261, 297, 353
hernia, perineal, 142
hormones/endocrine testing
ACTH, 405
cortisol (baseline or post-ACTH
stimulation test), 404
insulin, 405
oestradiol, 407
parathyroid hormone, 403
pro-BNP, 407
progesterone, 406–7
testosterone, 406
thyroxine, 401–3
vitamin D
(1,25-dihydroxycholecalciferol),
405–6
Horner’s syndrome
first order, 189
second order, 189
third order, 189–90
hyaline, associated with proteinuria, 388
hyperaemia (bulbar)/vascular
congestion



episcleritis, 196
glaucoma, 196–7
hyperbilirubinaemia, 316, 323, 335,
336, 383, 388
hypercalcaemia, 6, 11, 16, 20, 32, 33,
48, 116, 257, 263, 295, 339,
366, 367, 369, 373, 382, 389,
403, 406, 415
hyperglobulinaemia, 132, 203
hyperglycaemia, 20, 327, 332, 375,
383, 384, 405
hyperkalaemia, 16, 20, 32, 33, 66,
161, 372, 411, 413, 414, 415,
416, 417, 421
hyperlipidaemia, 55, 196, 323, 324,
336, 375, 397
hypernatraemia, 6, 16, 20, 65, 367
hyperpigmentation
drugs, 171
focal, 171
generalised/diffuse, 171–2
multifocal, 172
hyperproteinaemia, 375, 385
marked, 375
hypersthenuria, 382–3
hypertension, 15, 18, 21, 40, 42, 54,
55, 57, 64, 81, 90, 139, 156,
158, 159, 196, 201, 202, 203,
220, 222, 223, 240, 259, 292,
293, 294, 298, 300, 308, 309,
310, 314, 337, 353, 407, 412
adrenal disease, 132
anaemia, 132
CNS disease, 132
drugs/toxins, 132
endocrine disease, 132
hyperviscosity, 132
iatrogenic, 132
idiopathic, 132
renal disease, 132–3
systemic, 40, 42, 156, 158,
196, 203


Index 435



systemic arterial, 294
thyroid disease, 133
hyperthermia, 16, 17, 32, 58, 110,
150, 340, 377, 386
causes, 126
fever, 121–6
pathological, 126
hypertrophy/muscular swelling, 206
hyphaema, 92, 197, 203, 204
hypoalbuminaemia, 36, 130, 216, 259,
299, 308, 365
hypocalcaemia, 16, 20, 25, 32, 33, 65,
66, 84, 113, 201, 365, 403,
415, 416
hypocalcaemic tetany, 126
non-parathyroid causes, 403
hypoglycaemia, 16, 20, 52, 58, 65, 66,
68, 75, 82, 84, 90, 114, 153,
161, 327, 331, 384, 405, 422
persistent, 327
hypokalaemia, 6, 11, 16, 17, 20, 32,
33, 36, 48, 58, 59, 369, 372,
378, 380, 382, 413, 415, 416
hypomagnesaemia, 365, 370
hyponatraemia, 16, 20, 65
hypopigmentation
generalised, 170
localised, 170–171
hypoproteinaemia, 52, 152, 237, 365
liver disease, 231
protein-losing enteropathy, 231
protein-losing nephropathy, 231
hyposthenuria, 381–2
kidneys, inability, 382
solutes and increased water loss,
381–2
hypotension, 16, 18, 58, 294, 354
cardiac function, decreased, 133
preload, decreased, 133
vascular tone, decreased, 133
venous return, decreased, 134
drugs/toxins, 134–5



hypothermia, 16, 17, 32, 58, 110, 114,
127, 153, 160, 340, 370, 372,
373, 386, 415, 423
hypovolaemia, 81, 133, 150, 163, 224,
292, 293, 294, 340, 375


immune mediated/infectious, 68, 69,
70, 74, 79, 91
infectious agents
bacteria, 390
fungi, 390
parasites, 390
predisposing factors to urinary tract
infection, 390–392
infertility
female
intromission, 107–8
male factors, 107
ovulation failure, 108
male
congenital defects, 111
female factors, 108
inability to mount female, 109
intromission, 108–9
lack of fertility, 109
lack of libido, 109–10
low/absent sperm, 110–111
inflammatory cells, 401
inflammatory conditions, chronic, 19
inflammatory/infectious, 80, 122, 203,
205, 325, 334
insulin
decreased, 405
increased, 405
insulinoma, 6, 9, 10, 16, 17, 19, 75,
79, 186, 327, 331, 374, 382,
384, 405
intestinal blood loss, 342, 348
intestinal disease, small, 8, 10, 40, 326
intestines, abdominal radiography
large intestine, 249–51
small intestine, 244–9


436 Index



iron
decreased, 333
deficiency anaemia, 347
deficiency disorders, 325
increased, 333


jaundice
hepatic, 142–3
post-hepatic, 144
pre-hepatic, 142
joint changes, skeletal radiography
joint space, increased/reduced size,
271–2
mixed osteolytic/proliferative joint
disease, 272
osteolytic joint disease, 272–3
proliferative joint disease, 273
soft tissue swelling, joint
effusion, 274
subchondral osteolysis, 272
jugular distension/hepatojugular
reflux, 163


kidney
absent, 208
acute injury, 7, 24, 116, 208, 256,
257, 263, 324, 338–40, 345,
347, 365, 366, 371, 372,
374, 382, 385, 386, 388,
402, 405
chronic disease, 7, 24, 116, 257,
263, 324, 340, 345, 347,
365, 366, 371, 374, 382,
386, 388, 402, 405
cytology, 397
enlarged, 138, 207–8
inflammatory cells, 397
neoplastic cells, 397
non-visualisation, 257–8
radiopacity (increased), 257
renal pelvis dilatation, 255–7
small, 208, 258, 294



lactate dehydrogenase, 333–5
lameness
forelimb, 95–9
hindlimb, 99–103
multiple joint/limb, 103, 104
lens lesions
cataract, 200–201
luxation/subluxation, 201
lipase, 335–6
liver
amyloidosis, 395
bile pigment (increased), 395
cytology, 395–7
disease, 32, 33, 40, 42, 231, 298,
301, 315, 321, 326, 333, 363,
364, 375, 382, 402
focal enlargement, 237–8
generalised enlargement, 238
copper (increased), 395
infectious hepatopathies,
395–6
inflammatory hepatopathies, 396
neoplasia, 238–9
neoplastic cells, 396–7
palpation, abnormal
focal enlargement, 145–6
generalised enlargement, 144–5
reduced liver size, 146
reduced liver size, 239
vacuolar hepatopathies, 397
lockjaw _see_ trismus
long bones, skeletal radiography
abnormally straight, 264
angulation, 264
bowing, 265
irregular margination, 265
lymphadenopathy, 235, 249, 250,
252, 262, 297
lymph nodes, enlarged, 127–9
infiltration, 127–8
proliferation/inflammation,
128–9


Index 437



lymphocytosis
neoplasia, 357
physiological, 357–8
lymphopenia
drugs, 358
endocrine, 358
immunodeficiency syndromes, 358
infectious/inflammatory,
358–9
loss of lymph, 359
physiological, 359


malassimilation, 10
maldigestion/malabsorption, 8, 50,
314, 323, 409
mandible, head and neck
radiography, 276
mastocytemia, 361
maxilla, head and neck
radiography, 275
mediastinal shift, 224, 228, 235–6
megaoesophagus, 12, 14, 28, 215,
228, 229, 237, 402
melaena, 8, 408
extra-gastrointestinal disease, 40
gastrointestinal disease, 41–2
meningoencephalitis, 63, 68, 83, 130,
188, 400
microhepatica, 242, 245, 249, 297
monocytosis
chronic inflammation, 359
corticosteroids, 359
immune-mediated disease, 360
infections, 359–60
neoplasia, 360
motor neurone (upper) spinal cord
lesion, 253
murmurs
cardiovascular disease associated,
159–60
innocent, 159
physiological, 159



musculoskeletal signs
historical
forelimb lameness, 95–9
hindlimb lameness, 99–103
multiple joint/limb lameness, 103–4
muscular atrophy/hypertrophy, 204–6
trismus, 206–7
weakness, 207
myoglobinuria, 117, 385, 388


nasal flush cytology
inflammation, 394
neoplasia, 394–5
organisms, culture, 395
neck, ultrasonography
enlarged parathyroid gland(s), 311
enlarged thyroid gland(s), 311
lymph node enlargement, 311
neck masses at other sites, 312
salivary gland enlargement, 311
neonatal mortality
congenital abnormalities, 114
infections, 114
maternal/management factors, 114
neoplasia, metastatic/primary bone, 367
nephrotoxic drugs, 257, 263
nerve conduction velocity findings, 423
neurological disease, 11, 12, 20, 23,
25, 27, 38, 41, 43, 44, 85, 130,
133, 150, 209, 422
congenital, 87
degenerative, 87
drugs/toxins, 87–8
idiopathic conditions, 88
immune-mediated disease, 88–9
infectious, 89
metabolic, 89–90
neoplastic, 90
nutritional, 90
neurological signs
abnormal CN responses, 183–6
hemineglect syndrome, 190


438 Index



neurological signs ( _cont’d_ )
historical
altered behaviour, 82–5
ataxia, 67–76
coma/stupor, 80–82
deafness, 85–7
multifocal neurological disease,
87–90
paresis/paralysis, 76–80
seizures, 61–5
trembling/shivering, 65–7
Horner’s syndrome, 189–90
spinal disorders, 190–192
vestibular disease, 186–9
neutropenia
decreased neutrophil survival, 355–6
reduced neutrophil production, 356–7
reduced neutrophil release, 356
neutrophilia
immunodeficiency syndromes, 354
inflammatory conditions-acute or
chronic, 354–5
physiological, 355
primary, 355
reactive, 355
nodules
inflammation, 168
neoplasia, 168–9
non-neoplastic, non-inflammatory,
169–70


obstipation, 31, 33, 46–8, 138, 249,
250, 252
ocular signs
anterior chamber, 204
blindness/visual impairment, 90–93
corneal opacification, 197–8
corneal ulceration/erosion, 198–200
epiphora/tear overflow, 93–4
intraocular haemorrhage/
hyphaema, 203
intraocular/periocular



acquired, 91–2
congenital, 92–3
lens lesions, 200–201
red eye, 192–7
retinal lesions, 201–3
oedema
bronchial wall, 214
corneal, 197–8
early, 218
peripheral, 9, 152
generalised, 130–131
localised, 131
regional, 131
pulmonary, 21, 25, 52, 56, 59, 149,
155, 216–17, 378, 380
oesophagus abnormalities, thoracic
radiography
oesophageal dilatation, 225–7
oesophageal opacity (increased),
227–8
oestradiol (increased), 407
oestrus, failure to observe, 104
concurrent disease, 105
iatrogenic, 105
ovarian disease, 105
stress, 105
oliguric/anuric kidney injury, 210, 391
oral lesions
congenital deformities, 135
inflammatory masses, 136
neoplasia, 135–6
oral ulceration, 136
periodontitis/gingivitis, 136
salivary gland enlargement, 137
stomatitis, 137
tooth disease, 137
orthopaedic disease, 47, 109, 204
ossification (delayed)/growth plate
closure, skeletal radiography, 266
osteolysis, skeletal radiography, 270
osteolytic (mixed)/osteogenic lesions,
skeletal radiography, 271


Index 439



osteopenia, 264, 272–3
artefact, 268
disuse, 268
iatrogenic, 269
metabolic/endocrine/systemic, 269
neoplasia, 269
nutrition, 269–70
toxins, 270
otitis externa, 70, 87
extension of, 188
perpetuating factors, 177–8
predisposing factors, 177
primary causes, 176–7
ovarian and uterine disease, abdominal
ultrasonography
uterine enlargement, 305
uterine wall thickening, 305–6


pain
abdominal, 304
causes, 130
drugs/toxins, 138
gastrointestinal disease, 139
hepatobiliary disease, 139
mechanical factors, 139
mesenteric tension/traction/
torsion, 139–40
musculoskeletal pain, 140
organ rupture, 140
pancreas, 140
peritoneal cavity, 140–141
urinary system, 141
constipation, 47–8
diffuse
gastrointestinal disease, 130
musculoskeletal disease, 130
pallor
anaemia, 151
decreased peripheral perfusion, 151
drugs/toxins, 151
pancreatic disease, abdominal
ultrasonography



diffuse enlargement, 302
focal pancreatic lesions, 301–2
parathyroid hormone, 403
paresis/paralysis
peripheral nerves, 78–80
spinal disease, 76–8
partial thromboplastin time/activated
clotting time, 363–4
penis abnormalities
paraphimosis, 211–12
penile bleeding, 212
perianal swelling, 141–2
pericardial disease, 145, 163, 221,
231, 239
peripheral nerves (mono-/
polyneuropathies)
degenerative, 73–4, 78–9
drugs/toxins, 79
immune mediated/infectious,
74, 79
metabolic, 79
neoplastic, 74, 79
traumatic, 74, 80
vascular, 74, 80
peripheral neuropathy, 27, 50, 59,
67, 205
peripheral vestibular system, 186–8
pH
acidaemia, 377–8
alkalaemia, 378–9
pharynx, head and neck radiography,
279–80
pigmentation disorders
hyperpigmentation, 171–2
hypopigmentation, 170–171
pneumonia, 11, 16, 51, 57, 123, 124,
148, 149, 154, 215–6, 217,
218, 220, 231, 232, 237, 356,
378, 380, 402, 3952
pneumothorax, 15, 134, 150, 154,
215, 217, 224, 232–5, 233,
235, 378, 380


440 Index



pododermatitis
asymmetric, 178
symmetric, 179–80
pollakiuria/dysuria/stranguria
with haematuria, pyuria/
bacteriuria, 115
normal urine, 115
polycythaemia, 7, 19, 55, 116, 132,
203, 330, 354
primary, 349
relative, 348–9
secondary, 349–50
polyphagia, 10
polyuria/polydipsia
diet, 5
drugs/toxins, 5–6
electrolyte disorders, 6
endocrine disease, 6
hepatobiliary disease, 6
infectious disease, 6
neoplasia, 7
physiological, 7
renal disorders, 7
polyuria without polydipsia, 133
post-renal disease, 336
post-renal failure, 372
pre-renal disease, 320, 336
P–R interval
prolonged, 413
short, 413
pro-BNP (increased), 407
progesterone, 406–7
prostate
abdominal radiography
displacement, 260
enlargement, 260–261
abnormal on palpation, 210
prostatic disease, 47, 49, 109, 115,
116, 117, 119, 120, 306
protein-losing enteropathy, 8, 35,
231, 314, 323, 329, 336,
359, 364



protein-losing nephropathy, 8, 231,
314, 324, 364
prothrombin time, 363
pruritus
drugs/toxins, 59
endocrine disorders, 59
environmental, 59
immune-mediated disease,
59–60
infection, 60–61
keratinisation disorders, 61
neoplasia, 61
neurological, 61
ptyalism/salivation/hypersalivation
drugs/toxins, 22–3
nausea/regurgitation/
vomiting, 23
normal breed variation, 23
oral cavity disease, 23–4
physiological factors, 24
salivary gland disease, 24
pustules and papules
immune-mediated diseases, 167
infectious/parasitic diseases, 167
primary immune-mediated, 166
P wave alterations
absent, 411
tall P wave, 410
variable height, 410
wide P wave, 410
pyrexia, 2, 126, 386


QRS complex
deep S waves, 412
electrical alternans, 412
slurred upstroke, 413
small R waves, 412
tall R waves, 411
wide QRS, 412
Q–T interval alterations
prolonged, 415
shortened, 415


Index 441



red eye
anterior uveitis, 194–6
bulbar hyperaemia/vascular
congestion, 196–7
conjunctivitis, 192–4
regurgitation, 7, 8, 23, 158, 160, 215,
239, 292, 294, 410, 411,
412, 417
endocrine disease, 27
gastric disease, 27
immune-mediated disease, 27
neurological disease, 27–8
oesophageal disease, 28
salivary gland disease, 28
weight loss, 8
remodelling, periosteal, 265
renal disease, 8, 11, 12, 14, 20, 25, 26,
32, 33, 34, 65, 84, 90, 115,
117–18, 132–3, 133–4, 152,
166, 173, 298, 301, 302, 320,
326, 328, 330, 333, 336, 337,
343, 349, 369, 370, 375–7,
376, 377
diffuse abnormalities, 294–5
end-stage, 173, 294
focal abnormalities, 295–6
pelvic dilatation, 296–7
renal insufficiency, 332
renal mass, 261
renomegaly, 9, 245, 249, 250, 261,
294, 302
reproductive historical signs
abortion, 111–12
dystocia, 112–13
failure to observe oestrus, 104–5
female infertility, normal oestrus,
107–8
male infertility, 108–11
neonatal mortality, 114
oestrus behaviour, persistence, 105
prolonged inter-pro-oestrus
interval, 107



prolonged pro-oestrus/
oestrus, 106
shortened inter-pro-oestrus
interval, 107
short pro-oestrus, 106
vaginal/vulval discharge, 111
respiratory disease, 11, 15–16, 21, 25,
42, 43, 59, 153, 154, 161,
162, 207, 219, 334, 349,
378, 380, 410, 411, 414,
417, 421, 422
respiratory sounds, abnormal
crackles, 155
stertor, 155
stridor, 155–6
wheezes, 156
retinal detachment, 92, 197, 201,
203, 310
retinal lesions
detachment, 201
haemorrhage, 203
swollen optic disc, 202
rhinitis, 11, 24, 277, 278
rhythm alterations
atrial fibrillation, 416–17
atrial flutter, 417
atrioventricular block, 417
parasystole, 417
persistent atrial standstill, 417
sinus block/arrest, 417–18
supraventricular premature
complexes/tachycardia, 418
ventricular flutter/
fibrillation, 419
ventricular premature complexes/
ventricular tachycardia,
418–19
rib abnormalities, thoracic
radiography
congenital disorders, 224
new bone, 224
osteolysis, 224–5


442 Index



salivary gland disease, 24, 26, 28
scaling
exfoliative dermatoses, 164
primary/inherited disorders,
keratinisation, 164–5
secondary, 165–6
seizures, 17, 23, 52, 85, 126, 217, 334
extracranial, 64–5
intracranial, 61–4
shock, 15, 40, 42, 116, 150–151, 157,
162, 173, 221, 224, 241, 338,
340, 354, 377, 383, 421
distributive, 152
hypovolaemic, 152
hypoxaemic, 153
metabolic, 153
skeletal radiography
bony masses, 267–8
delayed ossification/growth plate
closure, 266
dwarfism, 265
fractures, 264
joint changes, 271–4
long bones, altered shape, 264–5
mixed osteolytic/osteogenic
lesions, 271
osteolysis, 270
osteopenia, 268–70
periosteal reactions, 267
radiopacity (increased), 266
skin disease
chronic, 386
erosive/ulcerative
drugs/toxins, 174–5
idiopathic, 175
infection, 175
neoplasia, 175
physical, 175
vasculitis, 175
scrapes/hair plucks/tape impressions
fungi, 398
parasites, 398

